Product Images Lisinopril And Hydrochlorothiazide

This text is a description of Lisinopril and Hydrochlorothiazide Tablets, USP. Each tablet contains 10 mg lisinopril, USP, and 12.6 mg hydrochlorothiazide, USP. It provides information on the usual dosage, storage instructions, and warnings. The tablets are to be kept out of the reach of children, stored at controlled room temperature, protected from excessive light and humidity, and dispensed in a tight, light-resistant container with a child-resistant closure. The product is marketed by GSMS, Incorporated, located in Camarillo, CA, USA, and manufactured by CorePharma, LLC in Middlesex, NJ, USA.*

This is a description of a medication containing Lisinopril and Hydrochlorothiazide in tablet form, with each tablet containing 10 mg Lisinopril and 12.6 mg Hydrochlorothiazide. The usual dosage and warnings are provided on the packaging. The product is distributed by GSMS, Incorporated and manufactured by CorePharma, LLC in the USA. It is available in a container that protects from light and humidity.*

This text contains information about a medication that is a combination of 20 mg lisinopril and 12.6 mg hydrochlorothiazide. The text also provides details about the dosage, storage instructions, and manufacturer information of the tablets. It mentions to keep the medication out of reach of children and to store at controlled room temperature. Additionally, it specifies to protect from excessive light and humidity and suggests dispensing in a tight, light-resistant container with a child-resistant closure.*

This is a description of Lisinopril and Hydrochlorothiazide tablets, USP, containing 20 mg of lisinopril, USP, and 12.6 mg of hydrochlorothiazide, USP. The prescription medication is to be stored at room temperature and protected from light and humidity. It is important to keep out of reach of children and dispense in a child-resistant container. Marketed by GSMS, Incorporated and manufactured by CorePharma, LLC.*

This text provides information about NDC 51407-566-05, which is Lisinopril and Hydrochlorothiazide tablets in a strength of 20mg/25. The medication contains 20 mg of Lisinopril, USP, and 25 mg of Hydrochlorothiazide, USP per tablet. It includes dosage instructions and storage requirements. The tablets should be kept out of reach of children, stored at room temperature, and protected from light and humidity. The medication is to be dispensed in a light-resistant container with a child-resistant closure. It is marketed by GSMS, Incorporated, located in Camarillo, CA, and manufactured by CorePharma, LLC in Middlesex, NJ.*

This text is a description of a medication with NDC 51407-566-90, Lisinopril and hydrochlorothiazide Tablets, USP. Each tablet contains 20 mg lisinopril, USP, and 26 mg hydrochlorothiazide, USP. It is indicated for prescription use only with a recommended usual dosage as provided in the accompanying Prescribing Information. The medication should be kept out of reach of children, stored at a controlled room temperature of 20°C to 25°C (68°F to 77°F), protected from excessive light and humidity, and dispensed in a tightly sealed, light-resistant container with a child-resistant closure. The product is marketed by GSMS, Incorporated in Camarillo, CA and manufactured by CorePharma, LLC at 215 Wood Ave, Middlesex, NJ. The revision date of the information is 11/24 40348.*